Zhao et al. (12) reported that FGF19 can inhibit the NF-κB signaling pathway to achieve anti-inflammatory effects, which is a key feature in the early stage of sepsis, and that the FGF19 may be a predictive biomarker of GI dysfunction. This evidence concerns the gene FGF19 and Sepsis.